Peptide Receipt
CJC-1295 vs Ipamorelin · Checked 2026-08-14
PR-DRAFT-MST625WI-5B701Y3H
Claim
“CJC-1295 and ipamorelin build muscle”
What people are actually reporting
Anecdotal · User-reported · Not clinical evidence
Here’s what keeps coming up in real user reports:
- strength gains
- lean muscle support
- skin improvements
- maintenance diet
LESS CONSISTENT REPORTS
- Potential for water retention or 'tingling' sensations.
- Confusion regarding the 'DAC' vs 'No DAC' versions of CJC-1295.
- Uncertainty about the timeline for seeing physical changes.
The receipt
Limited Evidence
Confidence · Low
While CJC-1295 and Ipamorelin are frequently marketed and used in the 'gray market' to build muscle, there is currently no robust clinical trial data in humans to prove they actually increase muscle mass. They work by stimulating growth hormone release, which theoretically supports muscle growth, but this effect has not been definitively established in peer-reviewed human research.
What the research says
Current research describes these peptides as 'performance-enhancing drugs' that modulate the GH-IGF1 axis. While they are studied for potential use in aging and orthopaedics, their use for muscle building remains largely experimental and anecdotal.
Evidence level
- Human evidence
- None
- Animal evidence
- None
- Lab evidence
- None
Sources
Research and educational information only. Not medical advice.